Fred Hutchinson Cancer Research Center has three Nobel Prizes hanging in its Seattle lobby and a worldwide reputation for the quality of its science. But one honor has remained elusive, until now: a creature named after it.
The U.S. has been incredibly fortunate to see COVID cases trending downwards nationwide for almost all of 2021. But despite the good news, experts are continuing to warn that the pandemic is far from over just yet, even though there has been an increase in the pace of vaccinations.
Breast cancer is the most commonly diagnosed cancer among women around the world, with Australia ranked among the top 10 countries with the highest rates. Now new research suggests developing a breast screening strategy targeting women from age 40, based on a baseline breast density measure, could be the most effective way to reduce breast cancer mortality.
Dr. Josh Schiffer, a Hutch infectious disease specialist who develops models of viral dynamics in infected people, reckons that prior to the SARS-CoV-2 pandemic, he'd spoken to news media just once. Now, he's spoken to Dr. Siddhartha Mukherjee for a story in the New Yorker and actor and TV personality Joel McHale for an interview series, Joel Asks Fred Hutch.
Ozette - the creators of a cutting-edge AI-powered Immune Monitoring Platform - recently announced $6 million in seed financing led by Madrona Venture Group. These are the details. Ozette - the creators of a cutting-edge AI-powered Immune Monitoring Platform - recently announced $6 million in seed financing led by Madrona Venture Group with participation from Allen Institute for Artificial Intelligence (AI2) and Vulcan Capital.
Seattle writer Christy Karras was one of the first people to recover from COVID-19 and write about it. A year later, she reflects on how her life has changed, what she has learned about the disease and what she's looking...
Click here for updates on this story Saskatoon, Saskatchewan ( CTV News) -- Scientists from across the U.S. and Puerto Rico are urging for more diversity in vaccine clinical trials after their new study exposed a decade's worth of disparity from 2011 to 2020, and could have impacted vaccination rates among minorities.
File photo Scientists say viruses reproduce and mutate at higher rates, creating viral variants. Nearly a year has passed since the COVID-19 outbreak began, and more than 100 million confirmed cases have been recorded worldwide. Mutated variants of the virus have recently garnered attention and concern.
Covid-19 survivors who have gotten a first dose of Covid-19 vaccine are generating immune responses that might render a second shot unnecessary, potentially freeing up limited vaccine supply for more people, several new research papers suggest.
For more than a decade, psychologist Dr. Michele Andrasik has been working in Seattle on ways to increase opportunities for underrepresented minorities at risk for HIV to participate in clinical trials of vaccines and drugs to prevent it.
Every organism gets two copies of its genes, one from each parent, but they don't always have the same effect. Fathers primarily provide DNA. Having evolved solely to shuttle male DNA to an egg cell, mature sperm consist of little more than tightly compressed DNA, a cell membrane and a rapidly churning tail.
A team of scientific experts from across the U.S. and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade's worth of disparities. The new study, published in JAMA Network Open, found that among U.S.-based vaccine clinical trials, people who are Black/African American, American Indian/Alaska Native, Hispanic/Latino and age 65 and older were the most underrepresented groups.
Even though the rollout has been rocky, COVID vaccines are here. The number of new COVID cases is dropping. Is it safe to feel a little optimistic about the future? Not just yet, say researchers at Fred Hutch. The U.K. variant, which is believed to be anywhere from 30% to 70% more transmissible, is here in Washington.
More than 800 questions were submitted ahead of a Washington Department of Health webinar on Thursday evening, during which state officials walked through the emerging COVID-19 vaccine rollout plan.
SEATTLE - February 19, 2021 - A team of scientific experts from across the U.S. and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade's worth of disparities.
As data shows racial disparities in COVID-19 vaccine distribution, a new study has found racial and ethnic inequities across nearly a decade of U.S. vaccine trials. Minority communities and older adults were underrepresented when compared to their overall percentage of the population, according to a study of more than 200 vaccine trials published Friday in JAMA Network Open.
Newswise - Seattle Cancer Care Alliance (SCCA), the only NCCN-designated cancer center in Washington State, has been selected as an authorized treatment center for the new chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel, also known as liso-cel and by the brand name Breyanzi TM. Liso-cel was approved by the U.S.
A Fred Hutchinson Cancer Research Center spinout, Ozette, raised $6 million in a seed round, the company announced Tuesday. Madrona Venture Group led the round, with participation from Allen Institute for Artificial Intelligence (AI2) and Vulcan Capital.
If you have questions about how Washington is handling the phased approach to rolling out COVID-19 vaccines, the state is providing a free hour-long expert panel on Thu., Feb. 18 at 5 p.m. The virtual event, titled "Understanding WA's COVID-19 Vaccine Phases" will be hosted on Zoom, and feature Washington Secretary of Health Dr. Umair A.
OLYMPIA - The state Department of Health will host a live webinar today to discuss the phasing and rollout of COVID-19 vaccines. The webinar, "Understanding WA's COVID-19 Vaccine Phases, will be from 5 p.m. to 6 p.m. State residents can register and submit vaccine questions in advance.